Application of artificial intelligence in oral potentially malignant disorders: current opinions and future barriers.
Oral potentially malignant disorders (OPMDs) refer to oral mucosal disorders with an increased risk of malignancy, primarily oral squamous cell carcinoma (OSCC), especially in South and Southeast Asia
APA
Guo X, He Y, et al. (2026). Application of artificial intelligence in oral potentially malignant disorders: current opinions and future barriers.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 28(3), 804-817. https://doi.org/10.1007/s12094-025-04043-4
MLA
Guo X, et al.. "Application of artificial intelligence in oral potentially malignant disorders: current opinions and future barriers.." Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 28, no. 3, 2026, pp. 804-817.
PMID
40885838
Abstract
Oral potentially malignant disorders (OPMDs) refer to oral mucosal disorders with an increased risk of malignancy, primarily oral squamous cell carcinoma (OSCC), especially in South and Southeast Asia. Since not all patients with OPMDs develop oral cancer, accurate early detection and diagnosis of malignant transformation are critically important for clinicians to determine the optimal therapeutic approach. Therefore, distinguishing OPMDs from early-stage OSCC is an increasing challenge in the clinic. Artificial intelligence (AI) technology has recently been shown to quickly identify high-risk conditions/lesions for screening oral cancer early. Moreover, the AI algorithm can also be used to determine the prognosis of OPMDs. In this review, we systematically summarize the medical records, oral images, pathological examinations, biomarkers, omics data and other aspects of the main outcomes of AI applied to address OPMDs-related issues. Furthermore, we discuss automated diagnostic systems and risk prediction tools for malignant transformation with pleasant outcomes and the potential to ultimately assist clinicians. Finally, we introduce the current challenges and barriers to AI in OPMDs on the premise that more advanced AI models and larger datasets will lead to the use of AI models in OPMDs.
MeSH Terms
Humans; Artificial Intelligence; Mouth Neoplasms; Early Detection of Cancer; Precancerous Conditions; Prognosis; Carcinoma, Squamous Cell
같은 제1저자의 인용 많은 논문 (5)
- Ginsenoside Rg5 inhibits colorectal cancer, at least partially by blocking the lysosomal degradation of colorectal cancer cells.
- A novel risk stratification strategy for precision prevention of gastric cancer based on clinicopathological features and IGFBP7.
- MRPS28 serves as a biomarker of diagnostic, prognostic, and immune modulation in pan-cancer and promotes breast cancer malignant phenotypes.
- Macrophage-Derived CuET Vesicles Synergistically Enhance Paclitaxel Efficacy by Inhibiting Tumor Growth and Boosting Immunity in Breast Cancer.
- Dysregulation of CircZNF79(5) Modulates YBX1 Stability and Selective Autophagy to Drive Hepatocellular Carcinoma Progression.